Your browser doesn't support javascript.
loading
von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week.
Van Belle, Eric; Vincent, Flavien; Rauch, Antoine; Casari, Caterina; Jeanpierre, Emmanuelle; Loobuyck, Valentin; Rosa, Mickael; Delhaye, Cedric; Spillemaeker, Hughes; Paris, Camille; Debry, Nicolas; Verdier, Basile; Vincentelli, André; Dupont, Annabelle; Lenting, Peter J; Susen, Sophie.
Afiliação
  • Van Belle E; CHU Lille, Université de Lille, Inserm U1011 - EGID, Institut Pasteur de Lille, Lille, France; CHU Lille, Institut Coeur Poumon, Cardiology, Lille, France.
  • Vincent F; CHU Lille, Université de Lille, Inserm U1011 - EGID, Institut Pasteur de Lille, Lille, France; CHU Lille, Institut Coeur Poumon, Cardiology, Lille, France.
  • Rauch A; CHU Lille, Université de Lille, Inserm U1011 - EGID, Institut Pasteur de Lille, Lille, France; CHU Lille, Hematology and Transfusion, Lille, France.
  • Casari C; Inserm, UMR_S 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Jeanpierre E; CHU Lille, Université de Lille, Inserm U1011 - EGID, Institut Pasteur de Lille, Lille, France; CHU Lille, Hematology and Transfusion, Lille, France.
  • Loobuyck V; CHU Lille, Université de Lille, Inserm U1011 - EGID, Institut Pasteur de Lille, Lille, France; CHU Lille, Institut Coeur Poumon, Cardiac Surgery, Lille, France.
  • Rosa M; CHU Lille, Université de Lille, Inserm U1011 - EGID, Institut Pasteur de Lille, Lille, France.
  • Delhaye C; CHU Lille, Institut Coeur Poumon, Cardiology, Lille, France.
  • Spillemaeker H; CHU Lille, Institut Coeur Poumon, Cardiology, Lille, France.
  • Paris C; CHU Lille, Université de Lille, Inserm U1011 - EGID, Institut Pasteur de Lille, Lille, France; CHU Lille, Hematology and Transfusion, Lille, France.
  • Debry N; CHU Lille, Institut Coeur Poumon, Cardiology, Lille, France.
  • Verdier B; CHU Lille, Institut Coeur Poumon, Cardiology, Lille, France.
  • Vincentelli A; CHU Lille, Université de Lille, Inserm U1011 - EGID, Institut Pasteur de Lille, Lille, France; CHU Lille, Institut Coeur Poumon, Cardiac Surgery, Lille, France.
  • Dupont A; CHU Lille, Université de Lille, Inserm U1011 - EGID, Institut Pasteur de Lille, Lille, France.
  • Lenting PJ; Inserm, UMR_S 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Susen S; CHU Lille, Université de Lille, Inserm U1011 - EGID, Institut Pasteur de Lille, Lille, France; CHU Lille, Hematology and Transfusion, Lille, France. Electronic address: sophiesusen@aol.com.
J Am Coll Cardiol ; 73(9): 1078-1088, 2019 03 12.
Article em En | MEDLINE | ID: mdl-30846101
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de von Willebrand / Gerenciamento Clínico / Implante de Prótese de Valva Cardíaca / Tomada de Decisão Clínica / Doenças das Valvas Cardíacas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de von Willebrand / Gerenciamento Clínico / Implante de Prótese de Valva Cardíaca / Tomada de Decisão Clínica / Doenças das Valvas Cardíacas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2019 Tipo de documento: Article